| Authors: |
Docken SS; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Macairan A; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Schlub TE; Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Varco-Merth B; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Okoye AA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Immonen TT; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Cromer D; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Davenport MP; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia. |
